ALB and hepatocellular carcinoma: In contrast, DRP1 silencing enhanced the proportion of EGFP‐positive cells driven by the CMV‐Numb or CMV‐Albumin promoters in HCC‐LM3YY2KO cells (Figure 7J; Figure S15B, Supporting Information).